Deutsche Bank’s Checkmate Pharmaceuticals, Inc. Common Stock CMPI Stock Holding History

Deutsche Bank’s Portfolio CMPI Stock Details CMPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-134,760	Closed	-$803K	–	4773
2021 Q2	$803K	Sell	134,760 -3,199	-2%	-$22.6K	﹤0.01%	2913
2021 Q1	$1.67M	Sell	137,959 -65,575	-32%	-$932K	﹤0.01%	2310
2020 Q4	$2.97M	Sell	203,534 -48,997	-19%	-$624K	﹤0.01%	1658
2020 Q3	$2.91M	Buy	+252,531	New	+$3.24M	﹤0.01%	1526

Other funds holding CMPI

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Deutsche Bank's CMPI Position: Q3 2021 in Review

Deutsche Bank sold out of Checkmate Pharmaceuticals, Inc. Common Stock (CMPI) in Q3 2021, closing a stake of 134,760 shares — an estimated $803K sold.

Deutsche Bank first reported a position in CMPI in Q3 2020 and held it in 4 quarters. The position peaked at $2.97M in Q4 2020. 31 funds tracked by Wall St. Rank hold CMPI as of Q3 2021.

Deutsche Bank reported no remaining Checkmate Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 134,760 Checkmate Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $803K.
Deutsche Bank first reported a position in Checkmate Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Deutsche Bank's Checkmate Pharmaceuticals, Inc. Common Stock position peaked at $2.97M in Q4 2020.
31 funds tracked by Wall St. Rank held Checkmate Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.